Immuron Limited (NASDAQ: IMRN),

Published May 7, 2026

Views 10.2K | Likes 334 | Comments 0

Views#1,642,488

Views#318,907

Channel

Emerging Growth Conference

Emerging Growth Conference

14.3K subs•1.37K videos•Feb 2021

Views

10,213

Likes

334

Comments

0

Performance vs. channel

Outlier score

Engagement rate

Revenue estimate

Total (all-time): $7 – $20

Based on estimated $0.7–$2 CPM.

More features coming

We're working on new analytics and tools. Stay tuned.

About

Immuron Limited (NASDAQ: IMRN), is a biopharmaceutical company focused on developing and commercializing orally delivered targeted polyclonal antibodies for the treatment of infectious diseases. Keynote speaker: Steve Lydeamore, CEO Immuron Limited (NASDAQ: IMRN),

Published: May 7, 2026
Made for kids: No

More features coming

We're working on new analytics and tools. Stay tuned.